[LXRX] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
03-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -6.77%
YoY- -39.30%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 24 28 39 35 37 14 23 2.88%
PBT -31,934 -30,494 -23,387 -24,587 -23,476 -25,611 -23,122 24.04%
Tax -1,029 216 292 580 96 -14 -90 408.26%
NP -30,905 -30,710 -23,679 -25,167 -23,572 -25,611 -23,122 21.36%
Tax Rate - - - - - - - -
Total Cost 30,929 30,738 23,718 25,202 23,609 25,625 23,145 21.34%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -128,770.83 -109,678.57 -60,715.38 -71,905.71 -63,708.11 -182,935.71 -100,530.43 17.96%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.16 -0.16 -0.14 -0.17 -0.16 -0.17 -0.16 0.00%
EPS Diluted -0.16 -0.16 -0.14 -0.17 -0.16 -0.17 -0.16 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.